Global /United States /Healthcare /Drug Manufacturers - Specialty & Generic /ERAO
chevron_leftBack
Energy Resource Abundance, Inc. logo

Energy Resource Abundance, Inc.

ERAO
OTCMKTS: ERAO Delayed
0.0056USD -1.8%
As of 14 June 2026, Energy Resource Abundance, Inc. has a market cap of $2.11M USD, ranking #47094 globally and #5981 in the United States. It ranks #4174 in the Healthcare sector, and #316 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
47094
Country Rank
5981
Sector Rank
4174
Industry Rank
316
Key Stats
Market Cap
$2.11MUSD
Net Income (TTM)
-$1.92MUSD
PB Ratio
-2.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Charles Havens open_in_new
Founded
2010
Website
wyckomaruv.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.8% 1.8% -5% -43% -79% -92%

News

Loading...

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
ERAO
Energy Revenue America Inc
ISIN: US29272F1066
TV:
SA:
YF:
GF:
BA:
MS:
0.0056 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Energy Resource Abundance, Inc.

Energy Resource Abundance, Inc. operates as a diversified health and wellness company that focuses on acquiring and developing brands that enhance consumer well-being. The company's mission is to deliver health and wellness products that improve quality of life. The company was formerly known as Energy Revenue America, Inc. Energy Resource Abundance, Inc. was founded in 2010 and is headquartered in Prescott, Arizona.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United States)
Name
Market Cap diff.
PE
$29.56B
1M%
-
INDV
$2.07B
1.54B GBP
98K%
-
NDOI
$1.8B
85K%
0.4
$1.76B
83K%
-
$1.33B
63K%
-
$1.02B
48K%
12.1
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$36.75B
108.92B ILS
2M%
24.2
$15.84B
107.34B CNY
751K%
16.0
CIPLA
$11.16B
1.06T INR
529K%
23.4
LUPIN
$11.04B
1.05T INR
524K%
22.7
$9.09B
61.6B CNY
431K%
80.6
$8.74B
7.57B EUR
415K%
-
chevron_leftBack